Home › Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform
 

Keywords :   


Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform

2015-02-27 01:59:32| drugdiscoveryonline Home Page

Nodality, Inc., which is focused on solving drug development challenges, recently announced research results from its lead immuno-oncology efforts based on applications of the Company’s Single Cell Network Profiling (SCNP) technology

Tags: data program single network

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
15.05Royal Mail owner poised to accept 3.5bn takeover bid
15.05Gold Bond Named Official Body Skin Sponsor of Sports Illustrated Swimsuit\'s 60th Anniversary Issue
15.05Dunn-Edwards Reveals New Multifamily Color Collection
15.05Kimberly-Clark Names Chief Growth Officer
15.05TV Personality Lo Bosworth and BIC Soleil Escape Razors Launch Limited-Edition Five Senses Shave Kit
More »